The 8 analysts offering 1 year price forecasts for CGON have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to CGON in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CGON EPS for the last quarter is −0.28 USD despite the estimation of −0.36 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of CG Oncology, Inc. financials and stay on top of what is up with the company.
In the next quarter CG Oncology, Inc. revenue is expected to reach 205.40 K USD. Check out CG Oncology, Inc. revenue and earnings and make informed decisions.
According to analysts, CGON price target is 66.75 USD with a max estimate of 86.00 USD and a min estimate of 52.00 USD. Check if this forecast comes true in a year, meanwhile watch CG Oncology, Inc. stock price chart and keep track of the current situation with CGON news and stock market news.
We've gathered opinions of 8 analysts rating CGON stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.